RT Journal Article
SR Electronic
T1 Demographic and Clinical Characteristics of Pediatric COVID-19 in Arkansas: March-December 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.18.22276587
DO 10.1101/2022.06.18.22276587
A1 Sanders, Sara C.
A1 Taylor, Maxwell D.
A1 Filipek, Jacob
A1 Williford, Dustin
A1 Nguyen, Cindy
A1 Fisher, Charalene R.
A1 Scheffler, Stephanie M.
A1 Smith, Emily S.
A1 Martin, Phoebe
A1 Latch, Rebecca L.
A1 Snowden, Jessica
A1 Wu, Chang L.
A1 Cantu, Rebecca M.
YR 2022
UL http://medrxiv.org/content/early/2022/06/21/2022.06.18.22276587.abstract
AB The COVID-19 pandemic reached the United States in early 2020 and spread rapidly across the country. This retrospective study describes the demographic and clinical characteristics of 308 children presenting to an Arkansas Children’s emergency department or admitted to an Arkansas Children’s hospital with COVID-19 in the first ten months of the COVID-19 pandemic, prior to the emergence of clinically significant variants and available vaccinations. Adolescents aged 13 and older represented the largest proportion of this population. The most common presenting symptoms were fever, gastrointestinal symptoms, and upper respiratory symptoms. Patients with multisystem inflammatory syndrome in children (MIS-C) had a longer length of stay than patients with acute COVID-19. Children from urban zip codes had lower odds of admission but were more likely to be readmitted after discharge. Nearly twenty percent of the study population incidentally tested positive for COVID-19. Despite lower mortality in children with COVID than in adults, morbidity and resource utilization are significant. With many Arkansas children living in rural areas and therefore far from pediatric hospitals, community hospitals should be prepared to evaluate children presenting with COVID-19 and to determine which children warrant transport to pediatric-specific facilities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the University of Arkansas for Medical Sciences gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.